Sean Nolan
2022
In 2022, Sean Nolan earned a total compensation of $1.9M as Chief Executive Officer and Director at Taysha Gene Therapies.
Compensation breakdown
| Option Awards | $1,800,276 |
|---|---|
| Salary | $25,000 |
| Other | $74,000 |
| Total | $1,899,276 |
Nolan received $1.8M in option awards, accounting for 95% of the total pay in 2022.
Nolan also received $25K in salary and $74K in other compensation.
Rankings
In 2022, Sean Nolan's compensation ranked 1,829th out of 5,625 executives tracked by ExecPay. In other words, Nolan earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,829 out of 5,625 | 68th |
Division Manufacturing | 956 out of 3,053 | 69th |
Major group Chemicals And Allied Products | 390 out of 1,380 | 72nd |
Industry group Drugs | 355 out of 1,281 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 90 out of 295 | 70th |
Source: SEC filing on May 8, 2023.
Nolan's colleagues
We found three more compensation records of executives who worked with Sean Nolan at Taysha Gene Therapies in 2022.